Skip to main content
KANGSTEM BIOTECH CO., LTD. logo

KANGSTEM BIOTECH CO., LTD. — Investor Relations & Filings

Ticker · 217730 ISIN · KR7217730001 KO Manufacturing
Open in API
Filings indexed 414 across all filing types
Latest filing 2021-10-25 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 217730

About KANGSTEM BIOTECH CO., LTD.

https://kangstem.com

KANGSTEM BIOTECH CO., LTD. is a biopharmaceutical company that researches and develops advanced stem cell therapies. The company focuses on creating treatments for rare, incurable, and autoimmune diseases, with a pipeline that includes therapeutic candidates for neurological disorders. Leveraging proprietary technologies for the isolation and mass culture of mesenchymal stem cells, Kangstem Biotech also develops and commercializes stem cell culture media and related cosmetic products. The company is dedicated to addressing unmet medical needs through the development of next-generation biopharmaceuticals.

Recent filings

Filing Released Lang Actions
[기재정정]기타경영사항(자율공시)(전환가액 조정(전환우선주))
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from a Korean company (Kangstem Biotech) regarding the adjustment of the conversion price for convertible preferred shares. This type of disclosure, which details changes to capital structure instruments like convertible securities, falls under 'Capital/Financing Update' as it directly relates to the company's financing activities and capital structure adjustments.
2021-10-25 Korean
기타경영사항(자율공시)(전환가액 조정(전환우선주))
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Kangstem Biotech regarding the adjustment of the conversion price for redeemable convertible preferred shares due to a capital increase (rights offering). This type of disclosure, which details changes to the capital structure and conversion terms of financial instruments, falls under the 'Capital/Financing Update' category as it directly relates to financing activities and capital structure modifications.
2021-10-22 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a capital increase through a rights offering). It details the number of shares issued, the total amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2021-10-21 Korean
증권발행실적보고서
Share Issue/Capital Change Classification · 100% confidence The document is a '증권발행실적보고서' (Report on the Results of Securities Issuance) filed with the Financial Supervisory Service (FSS) in South Korea. This document is a mandatory regulatory filing that details the final results of a capital raise (in this case, a rights offering/paid-in capital increase), including the number of shares issued, the amount of capital raised, the allocation of shares, and the intended use of proceeds. It is a formal post-issuance report, not an announcement of a report (RPA) or a general regulatory filing (RNS), as it contains specific financial and operational data regarding the capital change. Therefore, it falls under the 'Share Issue/Capital Change' category.
2021-10-21 Korean
유상증자또는주식관련사채등의청약결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a capital increase (paid-in capital increase/rights offering) for Kangstem Biotech. It details the subscription results, including the number of shares subscribed, subscription rates, and future schedules for payment and listing. This falls under the category of share issuance and capital changes.
2021-10-20 Korean
유상증자또는주식관련사채등의청약결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from Kangstem Biotech regarding the results of a rights offering (paid-in capital increase). It details the subscription results, including the number of shares subscribed, the subscription rate, and the handling of unsubscribed shares. This falls under the category of capital and financing updates, specifically related to share issuance and capital structure changes.
2021-10-15 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.